Economics
In the News
Anti-competitive behaviour in market for hydrocortisone tablets
4th March 2017
On the surface this is a classic example of anti-competitive behaviour in a duopolistic market.
The CMA has alleged that Concordia and Actavis signed illegal agreements which enabled high prices for a life-saving drug to be prolonged. Naturally the announcement has brought a wave of criticism for the businesses involved because the cost of higher prices for drugs routinely used in the NHS are ultimately paid for by the taxpayer.
Two pharmaceutical firms accused of driving up prices of an NHS life-saving drug with secret deal https://t.co/ovzRkL6P6j
— The Independent (@Independent) March 3, 2017
Recommended

Exam support for 2022
Online Grade Booster Courses for A-Level Exams in May & June 2022
Exam technique, advance information support, live revision and more from the tutor2u subject specialist teams